Literature DB >> 26740155

Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.

Nathalie Wambang1, Nadège Schifano-Faux2, Alexandre Aillerie3, Brigitte Baldeyrou4, Camille Jacquet3, Christine Bal-Mahieu4, Till Bousquet5, Sylvain Pellegrini3, Peter T Ndifon6, Samuel Meignan4, Jean-François Goossens2, Amélie Lansiaux7, Lydie Pélinski8.   

Abstract

Three series of indeno[1,2-c]isoquinolines bearing a ferrocenyl entity were synthesized and evaluated for DNA interaction, topoisomerase I and II inhibition, and cytotoxicity against breast human cancer cell lines. In the first and second series, the ferrocenyl scaffold was inserted as a linker between the two nitrogen atoms. In the last series, it was introduced at the end of the carbon chain. The present study showed that the ferrocenyl entity enhanced the topoisomerase II inhibition. Most compounds showed a potent growth inhibitory effect on MDA-MB-231 cell line with the IC50 in μM range.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Drug binding; Ferrocene; Indenoisoquinoline; Topoisomerase II inhibitor

Mesh:

Substances:

Year:  2015        PMID: 26740155     DOI: 10.1016/j.bmc.2015.12.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Effects of Ferrocenyl 4-(Imino)-1,4-Dihydro-quinolines on Xenopus laevis Prophase I - Arrested Oocytes: Survival and Hormonal-Induced M-Phase Entry.

Authors:  Guillaume Marchand; Nathalie Wambang; Sylvain Pellegrini; Caroline Molinaro; Alain Martoriati; Till Bousquet; Angel Markey; Arlette Lescuyer-Rousseau; Jean-François Bodart; Katia Cailliau; Lydie Pelinski; Matthieu Marin
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

2.  A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas.

Authors:  Caroline Molinaro; Nathalie Wambang; Till Bousquet; Anne-Sophie Vercoutter-Edouart; Lydie Pélinski; Katia Cailliau; Alain Martoriati
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 3.  Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules.

Authors:  Eslam B Elkaeed; Hayam A Abd El Salam; Ahmed Sabt; Ghada H Al-Ansary; Wagdy M Eldehna
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

4.  Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line.

Authors:  Neelam Mishra; Kavita Rana; Siva Deepthi Seelam; Rakesh Kumar; Vijyendra Pandey; Bharathi P Salimath; Dayanand Agsar
Journal:  Front Bioeng Biotechnol       Date:  2021-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.